Biologics
-
Biologics
The ABCs of HCT/Ps
Navigating the complex regulatory pathway of human cell and tissue products.Lindsay Kleinwaks, Ph.D., Associate, Regulatory Affairs, MCRA 05.23.19
-
3-D Printing/Additive Mfg. | Biologics | Extremities | Materials
A Little Extreme: Factors Impacting the Extremities Implants Segment
3D printing, surgical planning, and innovations that simplify procedures increasingly are shaping the global extremities market.Michael Barbella, Managing Editor 05.23.19
-
Biologics | Bracing/Prosthetics
The Changing World Around Orthopedic Implants
Those who have been in this industry for more than a few years realize implant technology has not changed all that much. Sure, there are new product releases offering innovative benefits not previously available. Further, emerging manufacturing techn…Sean Fenske, Editor-in-Chief 05.23.19
-
Biologics
SINTX and EU Consortium Collaborate on Silicon Nitride Development
Silicon nitride offers the mechanical strength, chemical stability, and biocompatibility needed to manufacture spinal implants.Globe Newswire 05.21.19
-
Biologics
Parametrics Medical Partners with DePuy Synthes to Provide Allografts for Sports Medicine Repairs
Agreement supports Parametrics’ and DePuy Synthes’ shared commitment to a comprehensive sports medicine procedural focus.Parametrics Medical Inc. 05.16.19
-
Biologics
ISASS Bone Grafting Policy Statement Features i-FACTOR Peptide Enhanced Bone Graft
Society states Cerapedics' drug-device combination technology is shown to be safe and effective as autograft replacement with clinical evidence.Cerapedics 04.29.19
-
Biologics
First Successful Surgeries with Exactech's InterSep Calcium Sulfate Bone Void Filler
InterSep is a 100 percent synthetic calcium sulfate bone void filler that is engineered to fully resorb and replace bone during the healing process.Business Wire 04.17.19
-
Biologics | Extremities | Trauma/Sports
3D-Printed Tissues May Keep Athletes in Action
Rice U. bioengineers lead an effort to print scaffolds to heal bone and cartilage.Rice University 03.29.19
-
Biologics
Bioventus Launches OSTEOAMP SELECT Fibers
Fibers are uniquely processed to retain essential growth factors supporting bone formation and the nanotextured fibers provide a conduit for cell migration.Bioventus 03.27.19
-
Biologics | Large Joint
'Cell-Sheet Accelerating Technology' Offers Promising Treatment for Knee Arthritis
An approach combining conventional surgery and chondrocyte cell-sheet transplantation is a promising therapy for OA of the knee.PR Newswire 03.25.19
-
Biologics
Disrupting the Ceramic Bone Graft Substitute Sector
NuVasive's AttraX drives increased bone formation, faster fusion than traditional ceramic bone grafts.Online Exclusives Michael Barbella, Managing Editor 03.21.19
-
Biologics
MTF Biologics Introduces CartiMax Viable Cartilage Allograft
New putty-like tissue form designed to easily fill cartilage lesions in the knee, foot and ankle.MTF Biologics 03.20.19
-
Biologics
Biologics' Backbone
The explosion in spinal fusion procedures is leading to the development of innovative regenerative treatments.Online Exclusives Michael Barbella 03.18.19
-
Biologics
Unconventional Solutions
Seed Biotech developing orthobiologics solutions from 'alternative sources.'Online Exclusives Michael Barbella, Managing Editor 03.15.19
-
Biologics
AAOS News: Fidia Pharma USA Introduces NuDYN Allograft
NuDYN is the first product in Fidia’s new Orthobiologics portfolio; a novel acellular amnion-derived injectable allograft.Fidia Pharma USA 03.13.19
-
Biologics
Smith & Nephew Acquires Osiris Therapeutics for $660M
Osiris makes regenerative medicine products, including skin, bone graft, and articular cartilage substitutes.PR Newswire 03.12.19
-
Biologics
Orthobiologics' Precious Balance
Harmonizing patient outcomes, long-term safety/efficacy, and costs is the secret to success in the orthobiologics market.Online Exclusives Michael Barbella, Managing Editor 03.12.19
-
Biologics
Orthobiologics' High Reward
Demand for regenerative treatments is fueling growth in the sector, but the high cost of these therapies could curb overall market expansion.Online Exclusives Michael Barbella, Managing Editor 03.07.19
-
Biologics
Myoscience to be Acquired by Pacira
The company’s iovera° system offers targeted, long-lasting non-opioid pain management.Business Wire 03.05.19
-
Biologics
Natural Selection: Biologics in Orthopedics
With their healing prowess and cost-effectiveness, stem cells and bone graft substitutes are increasingly gaining traction in the orthobiologics sector.Michael Barbella, Managing Editor 02.13.19
